We have purified -6600-fold an =40-kDa protein (Ter protein) encoded by Eschenchia coli that specifically binds to two sites at the 216-base-pair replication terminus (7) of the plasmid R6K. Chemical footprinting experiments have shown that the Ter protein binds to two 14-to 16-base-pair sequences that exist as inverted repeats in the 7 fragment. Site-directed mutagenesis of one of the terminus sequences (TR) resulted in a mutant TR that failed to bind to the Ter protein. The same mutant terminus also failed to terminate DNA replication in vivo. These experiments strongly suggest that the interaction of the Ter protein with 7 sequences plays an essential role in the termination of DNA replication, specifically at 7.
Ter protein. The same mutant terminus also failed to terminate DNA replication in vivo. These experiments strongly suggest that the interaction of the Ter protein with 7 sequences plays an essential role in the termination of DNA replication, specifically at 7.
DNA replication can be divided into three steps-namely, initiation, ongoing replication, and termination. The ongoing replication step has been largely unraveled through analyses of several model replicons (for a review, see ref. 1) . Progress has been made in the analyses of initiation of replication and its control (1) . However, the termination step remains largely unclear.
The plasmid R6K initiates replication by interaction of Pi protein at one of three origins of replication (2, 3) and terminates DNA replication at a specific sequence called the terminus (T) that was revealed by in vivo experiments (2, (4) (5) (6) . By using gap filling of newly terminated daughter molecules and molecular cloning, T was localized in a 216-base-pair (bp) Alu I fragment (7) . The nucleotide sequence of the 216-bp terminus region was also reported (8) . Using an in vitro replication system, Germino and Bastia (9) reported that Escherichia coli contained soluble protein(s) that terminated DNA replication of pBR322 specifically at 7 when the 216 bp was cloned in it. These experiments strongly suggested that a host-encoded protein(s) is likely to be involved in the termination process, probably by binding to the sequence. Previously, it was reported (6) that 7 worked in either orientation.
In this report, we describe the identification and purification of a protein encoded by E. coli that specifically bound to a 14-to 16 -bp sequence at two physically separable sites called TR and 'TL that are located as inverted repeats in the 216-bp T fragment. We mutated 6 of 16 nucleotides of the Ter protein recognizing sequence TR, and we observed that the mutations not only abolished binding of the site by Ter protein in vitro but also inactivated the ability of the mutated sequence to terminate DNA replication in vivo, thus assigning a key role to the Ter protein in the termination process.
MATERIAL AND METHODS
Plasmids. pUC18-80 and pUC19-80 are plasmids containing the 80-bp TR sequence in opposite orientations with respect to the origin.
Purification of Ter Protein. Ter protein was purified from E. coli cells containing pUC19-2160 that were grown to midlogarithmic phase and then amplified for 3-4 hr with chloramphenicol (170 ,ug/ml). All subsequent steps were performed at 0°C-4°C.
Step 1 involved enrichment ofTer protein by exploiting its in vivo affinity for the plasmid TR sequence (10) . Wet packed cells (40 g) were suspended in 150 ml of buffer A [50 mM Tris-HCl, pH 7.5/2 mM EDTA/25% (wt/vol) sucrose/1 mM phenylmethylsulfonyl fluoride] to which 30 ml of lysozyme (10 mg/ml) in 250 mM Tris HCl (pH 7.5) was added. After 10 min, 30 ml of 250 mM EDTA was added. After 10 more min, 210 ml of buffer B (50 mM Tris HCI, pH 7.5/10 mM EDTA/0.1 mM dithiothreitol/0.4% sodium deoxycholate/1% Brij 58) was added and mixed gently for 15 min at 0°C. The lysate was cleared at 100,000 x g for 1 hr. The supernatant constituted fraction I. The plasmid DNA-protein complex was precipitated by adding polyethylene glycol 6000 (PEG) to 10%. After centrifugation, the pellet was dissolved in buffer C (50 mM Tris-HCI, pH 7.5/1 mM EDTA/200 mM NaCI/10 mM 2-mercaptoethanol). PEG was added to 5% and the pellet was redissolved in buffer C that contained 2 M NaCl. The plasmid DNA was precipitated away from stripped protein by adding PEG to 5%. The NaCl was removed by dialysis against Mono Q buffer, 20 mM Tris-HCI, pH 7.5/1 mM EDTA/10 mM 2-mercaptoethanol (fraction II), loaded onto a 10-ml heparin-agarose column (step 2). After washing with the same buffer, the column was eluted with 0-1 M NaCl gradient (60 ml) in Mono Q buffer. Fractions (1 ml) were collected. Ter activity, which eluted at 0.375 M NaCl, was measured by the gel shift assay using 20 fmol of labeled rR probe (11) . As described later, the specificity of the assay was worked out using appropriate protein and competitor DNA concentrations. Peak fractions were pooled (recovery was =50% of fraction II) and was called fraction III. The fraction III was dialyzed against Mono Q buffer and loaded in five separate aliquots onto a 1-ml Mono Q column that was eluted with 30 ml of 0-0.3 M NaCl in Mono Q buffer (step 4). A typical elution profile and the assay of peak fractions are shown in Fig. 1 . The Ter activity eluted at 0.09 M NaCI. The recovery was 90o of fraction III. One unit of Ter activity is arbitrarily defined as that amount able to fully shift 1 fmol of 80-bp TR DNA (specific activity, 106 cpm/,ug) in a gel shift assay in the presence of 100-fold excess of nonspecific sonicated calf thymus competitor DNA. Table 1 shows the degrees of purification from fractions I-IV. Although Ter activity in fraction I was difficult to measure with precision, we estimate that the in vivo affinity enrichment procedure yielded >100-fold purification of Ter at fraction II. The overall purification was at least =6600-fold over fraction I. The protein at this stage is free of endo-and exonuclease and nonspecific DNA binding activity (data not shown).
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Preparation of Replicative Intermediates. This was carried out as published (12) .
Copper-Phenanthroline Footprints. This was performed as described (13) .
Photoaffinity Labeling of Ter Protein. Using bromodeoxyuridine-substituted and 32P-labeled X DNA, the labeling of protein was carried out as described (14) .
Site-Directed Mutagenesis. Using the 19-mer described below, TR was mutated to mutant TR that has acquired a BgI II site. The procedure is published (15) .
RESULTS
Strategies for the Purification of Ter Protein. Previous work (9) had shown that soluble protein fractions from E. coli were capable of terminating DNA replication in vitro at r. We therefore expected that at least a certain population of the putative Ter protein should exist in a soluble form in the host cytoplasm. We introduced the high copy number plasmid pUC19 containing a single copy ofthe 216-bp r sequence, that was cloned between the EcoRI and HindIII sites of the vector, into E. coli, with the expectation that multiple copies of the r sequence present in the cell milieu would sequester the putative Ter protein in vivo in the form of DNA-protein complexes.
The Ter protein sequestered by X plasmid in vivo was purified >6600-fold through heparin agarose and Mono Q anion-exchange columns as described. The elution profile of the final column is shown in Fig. 1 . Table 1 The specificity of interaction of the protein with X sequences was established by competitive gel shift assay (11) . Gel shift assays in the presence of competitor DNA showed that the fraction III protein bound to the 216-bp rfragment at 66 Although it is difficult to make precise estimates of Ter activity in fraction I, our minimum estimate is that fraction II is 100-fold enriched over fraction I in specific activity. The overall minimum purification is, therefore, 6600-fold. least at two sites (Fig. 2, lane F) as revealed by two discrete bands of DNA-protein complex that were resolved after polyacrylamide gel electrophoresis. When the rfragment was cleaved with Hae III into an -140-bp and an -80-bp subfragment, each subfragment upon interaction with Ter protein revealed the formation of a single band of DNAprotein complex (Fig. 2, lanes B and D) . Therefore, both the -140-bp and the -80-bp subfragments apparently contained at least one Ter binding site. These sites will be called TL and TR (Fig. 3 A and B) . We monitored the sequence specificity of the DNA-protein interactions in two ways-first, under identical concentrations of the salt and competitor DNA, the protein bound specifically to the 216-bp T fragment but not to the replication origin y (280 bp) fragment of R6K (Fig. 2 , lane K) or to a fragment containing a piece of the ,3-lactamase gene of pBR322 (Fig. 2, lane H) . Second, whereas the binding of Ter protein to labeled r sequence could be blocked by competition by adding 10-fold excess of unlabeled homologous competitor DNA, it required, in contrast, a 500-fold excess of heterologous DNA (pUC19 DNA) to achieve the same level of competition (data not shown).
On the basis of the magnitude of the change in mobility of the T DNA fragment when complexed with Ter protein, we estimated, using a recently published procedure (16) , that the molecular mass of the protein binding to X fragment was -80 kDa. If the Ter protein were a dimer, then the monomer molecular mass should be :40 kDa. We wished to identify 5 ). Arrows show the direction in which replication fork is blocked at TL and TR. The sequence shown was previously published (7, 8) . (C) Site-directed mutagenesis of TR that replaced 6 of 14 bases with a Bgl II site. The mutant TR is nonfunctional. more definitively the size of the Ter protein in the partially purified protein fractions in the following manner.
Cross-Linking of Ter Protein with Labeled Sites. We cloned the 216-bp T sequence into M13mpl9 vector and, using a sequencing primer, synthesized a complementary strand, incorporating bromodeoxyuridine triphosphate, [a-32P]dATP, and [a-32P]dCTP into the newly synthesized DNA.
The bromodeoxyuridine-substituted and 32P-labeled r fragment was cut out of the M13 DNA, and the labeled probe was mixed with Ter protein fractions and irradiated with short wavelength UV light (14) . The following controls were performed. The Ter protein was also mixed with 32P-labeled and bromodeoxyuridine-substituted ori y DNA. The crosslinking of T DNA to Ter protein was performed in the presence of specific and nonspecific competitor DNA. The results (Fig. 4) show that when excess DNA probe is digested away from the cross-linked DNA-protein complex and the products are analyzed in 15% SDS/polyacrylamide gels, an -14-kDa protein and an =40-kDa protein were specifically labeled by the Ter probe (Fig. 4, lanes A, C, A and B) . Fivefold excess of nuclease did not change the mobility of the 40-kDa and 14-kDa bands (lane D). In the control bromodeoxyuridine-substituted 32P-labeled ori y probe, we observed that the ori y probe did not label the 40-or the 14-kDa protein (data not shown). These results strongly suggest that the 40-kDa protein is most likely the Ter monomer and the 14-kDa protein may be a degradation product or an accessory protein. However, with purer Ter protein (e.g., fraction IV), photoaffinity labeling only labeled the 40-kDa protein (data not shown). It should be kept in mind that mobility of the cross-linked protein reflects the bound DNA. Therefore, the real molecular mass of the Ter protein should be somewhat less than 40 kDa.
Chemical Footprints of Ter Protein at X Sequences. To identify the sequences recognized by the Ter protein, we performed copper-phenanthroline footprinting of the Ter protein at the T fragment by a recently described technique (13) . The 216-bp fragment was cleaved by Hae III into -140-bp and -80-bp subfragments (Fig. 3A) . These subfragments were 5'-and 3'-end-labeled with 32p separately at the HindIII, Hae III, and EcoRI ends. The asymmetrically endlabeled DNAs were complexed with protein. The DNAprotein complexes were resolved from free DNAs by gel electrophoresis. The gel slices were treated with copperphenanthroline, and the cleaved DNA eluted and resolved in denaturing sequencing gels.
The results ( results. The footprint of the top strand was displaced to the right by two nucleotides with respect to the bottom strand (data not shown). Therefore, there is no preferential protection of one strand of TR or TL by the Ter protein.
Site-Directed Mutagenesis of TR. We wished to examine whether the Ter protein plays a key role in the termination of DNA replication at TR (and TL) in the following manner. Using the synthetic oligonucleotide 5'-CTAGTAGagatct-CACTCA-3', we mutagenized 6 of 16 bases of TR that are protected by Ter protein. The mutants were selected by hybridization to 5'-end-labeled mutagenic oligonucleotide followed by washing at increasing temperatures as described (15) . Furthermore, the mutant acquired a Bgl II site that was easily confirmed by digestion with Bgl II (Fig. 2, lane 0) and by dideoxynucleotide sequencing (data not shown).
We examined the mutant TR (Fig. 3C) , first for its ability to bind to Ter protein, and second for its ability to terminate DNA replication in vivo.
The 80-bp mutant TR failed to bind to 20 units ofTer protein under conditions under which wild-type TR readily bound to 10 units ofTer protein (fraction IV) as revealed by the gel shift assay (Fig. 2 , lanes M and P).
Termination ofReplication in Vivo. We cloned the wild-type TR and the mutant TR in both orientations with respect to ori, between the EcoRI and the HindIII sites of pUC18 and pUC19. The wild-type TR should block fork movement in pUC18 but not in pUC19 because of the polarized nature of the block (17) . We prepared replication intermediates from both the wild-type and mutant TR clones and carried out the in vivo Ter assay described earlier (12) . The assay relies on the fact that the majority ofthe replication intermediates have the structure shown in Fig. 6 
DISCUSSION
The evidence presented in this paper supports the important conclusion that a sequence-specific replication terminus is specifically recognized by a host-encoded sequence-specific DNA-binding protein and that this interaction, most likely, is essential for blocking replication fork movement.
Is a specific replication terminus a universal feature of a replicon? A review of the available information shows that replicons such as phage A at the early stage of replication (18) and simian virus 40 (19) do not have a specific replication terminus. Perhaps it is worthwhile to keep in mind that these are "runaway" replicons that are apparently not regulated. A specific terminus is more likely to be present in bidirectionally replicating circular replicons such as the chromosomes of E. coli (20, 21) and R6K (2, (4) (5) (6) (7) (8) (9) that are regulated with respect to their copy number. Unidirectionally replicating plasmids such as ColEl terminate replication at or near the origin (22) .
What is the physiological role of a specific replication terminus? Clearly, the replication termini can be deleted from the chromosomes of R6K (5) and E. coli (23) without incurring any apparent lethality. However, E. coli strains with deleted termini grow more slowly (24) .
Is the Ter protein that terminates replication at TL and TR of R6K also the same protein that terminates DNA replication at the terminus of E. coli? Hill et al. (24) reported that termination in E. coli requires an unidentified trans-acting factor. It is very likely that the Ter protein also terminates host replication and that the T-like sequence may be a universal termination signal in E. coli and replicons that are similar to E. coli in other Gram-negative bacteria. The termini of R6K and E. coli show sequence homology (25, 26 
